Invesaro

Stocks MTCH Financial statements

Financial statements

Match Group, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Match Group, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue3,1403,3071,7302,0512,3912,9833,1893,3653,4793,487
Cost of revenue7566519111,127636839960954991948
Gross profit2,3842,6568199241,7552,1442,2292,4102,4882,539
Research and development213251132152170241334384442450
Selling and marketing1,2471,381420427480566535586622626
General and administrative530719182256311415436414439486
Operating income-32.6188549645746852515917823873
Interest expense10910594.6111131130146160160148
Interest income4.94.42.74.3726.841.121.9
Other non-operating income60.7-16.27.51-2.0315.9-4658.0319.840.821
Pre-tax income-81.167462532631256377777704746
Income tax-64.9-29111.315.143.3-19.915.4125153133
Income from continuing operations-41.5366414528277364652551
Net income to minority interests25.153.113111359.3-1.17-2.03-0.070.040.02
Net income-41.3305627454162278362652551613
EBITDA39.1263584680787893559979911940
EPS, basic-0.241.763.482.500.731.011.282.362.122.53
EPS, diluted-0.241.473.052.150.660.931.242.262.022.38
Shares, basic (weighted)173173180182223275283276260243
Shares, diluted (weighted)173184197202256305295293279262
Dividend per share0.000.000.190.76

Balance sheet

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash and equivalents1,3292731874667398155728629661,028
Short-term investments512320011.88.726.24.733.46
Receivables220304279116137188192299325303
Other current assets20418522897.914420310910410292.5
Total current assets1,8432,1252,7633,7081,0201,2188821,2711,3981,427
Property, plant and equipment306315319101108163176195158131
Lease right-of-use assets034.48511493.795.786.4102
Goodwill1,9242,5591,2451,2401,2712,4122,3482,3432,3112,339
Intangible assets355664631228231772358306215193
Long-term investments12365235353
Other non-current assets92.173.313564.2124163141134121154
Total assets4,6465,8686,8758,3653,0465,0634,1834,5084,4664,461
Accounts payable62.976.674.920.229.237.913.713.218.39.58
Accrued liabilities345367435182232768290307365422
Deferred revenue286342210219239262253211166151
Short-term debt2013.813.813.8010100424
Total current liabilities7138008841,0105001,1685565325491,007
Long-term debt1,5821,9792,2462,8903,8413,8293,8363,8423,8493,549
Lease liabilities2683.511497.498.584.6102
Other non-current liabilities44.238.266.826.286.411610410285.9104
Total liabilities2,6352,9213,3644,7374,4605,2594,5424,5274,5294,714
Total debt1,6232,1022,3482,8903,8413,8293,8363,8423,8493,549
Paid-in capital11,92212,16512,02211,6847,0898,1648,2748,5298,7568,721
Retained earnings2905951,2591,690-8,422-8,145-7,783-7,131-6,580-5,966
Treasury stock-10,177-10,227-10,310-10,31000-482-1,033-1,791-2,586
Other comprehensive income-166-104-129-136-81.5-224-369-385-450-423
Shareholders' equity1,8692,4302,8432,928-1,414-204-360-19.5-63.7-254
Minority interests1415177099701.047.930.990.4800.11
Total equity2,0112,9473,5113,628-1,413-196-359-19.1-63.7-253
Total liabilities and equity4,6465,8686,8758,3653,0465,0634,1834,5084,4664,461
Shares outstanding267283280269251233

Cash flow statement

FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Net income-16.2358758567222277360651551613
Depreciation and amortization71.774.334.834.441.341.443.661.887.567.1
Stock-based compensation1052656689.7102147204232267258
Deferred income tax-119-285-23-12.815.4-58-3026.6-1544.9
Change in receivables1.28-11517.3-17.9-24.2-34-6.67-107-29.823.6
Change in payables-52.4-25.321.433.724.2459-473-5.96-9.417.2
Cash from operations3444179889387899125268979331,080
Capital expenditures-78-75.5-31.4-39-42.4-80-49.1-67.4-50.6-56.8
Acquisitions-18.4-1471.14-3.760-860-25.7-11.6
Purchases of investments-314-29.9-450-59.6
Sales and maturities of investments172186137165
Cash from investing12.942-173-330-3,922-940-71.7-76.6-58.5-46.8
Debt issued4003501,000500000700
Debt repaid0-74.40-303-4000000-425
Stock issued001,42200136.50.4
Share buybacks-309-56.4-133-21600-482-546-753-789
Dividends paid00-1050000-186
Cash from financing-492-197-3134001,788111-689-534-758-985
Exchange rate effect-6.4311.6-1.89-1.575.43-7.57-7.813.78-12.313.2
Net change in cash-1412735001,007-2,40176.2-24329010461.8
Free cash flow2663419578997468334778298821,024
Interest paid10792.575.885.6116118138152153124
Income taxes paid69.135.640.734.64154.86010214599.5

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $40.55 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin74.8%Gross profit / revenue.
Operating margin28.2%Operating income / revenue.
EBITDA margin29.8%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin24.6%Pre-tax income / revenue.
Net margin20.2%Net income / revenue.
FCF margin32.5%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin34.4%Cash from operations / revenue.
Effective tax rate18.0%Income tax / pre-tax income, when pre-tax income is positive.
Return on assets (ROA)17.5%Net income / average total assets.
Return on invested capital (ROIC)29.6%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue12.7%Research and development expense / revenue.
Stock-based pay / revenue6.9%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue1.9%Capital expenditures / revenue.
D&A / revenue1.6%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y0.2%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y3.0%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y7.8%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y2.0%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y4.4%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y7.7%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y6.0%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y19.2%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y3.2%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y3.2%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y18.9%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y3.6%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y11.3%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y19.2%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y30.5%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y17.8%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y24.3%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y29.2%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y15.8%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y27.1%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y6.5%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y16.0%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y29.0%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y6.5%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y300.0%Dividend per share vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y-0.1%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y2.2%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y7.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-5.9%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-3.8%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y0.5%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio1.72xCurrent assets / current liabilities.
Quick ratio1.56x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio1.06x(Cash + short-term investments) / current liabilities.
Debt / assets88.1%Total debt / total assets.
Liabilities / assets105.9%Total liabilities / total assets.
Net debt$2.97BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA2.84xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage5.99xOperating income / interest expense.
Working capital$399.9MCurrent assets - current liabilities.
Goodwill and intangibles / assets61.7%(Goodwill + intangible assets) / total assets.
Tangible book value-$2.73BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.87xRevenue / average total assets.
Fixed asset turnover24.0xRevenue / average property, plant and equipment.
Receivables turnover12.6xRevenue / average receivables.
Days sales outstanding29 days365 x average receivables / revenue.
Days payables11 days365 x average accounts payable / cost of revenue.
FCF conversion161.3%Free cash flow / net income, when net income is positive.
Capex / operating cash flow5.5%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$2.86Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share$14.16Revenue / diluted weighted shares.
FCF per share$4.61Free cash flow / diluted weighted shares.
Operating cash flow per share$4.87Cash from operations / diluted weighted shares.
Book value per share-$1.03Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$11.85Tangible book value / shares outstanding.
Cash per share$2.54(Cash + short-term investments) / shares outstanding.
Payout ratio25.7%Dividends paid / net income, when net income is positive.
Dividends / FCF16.0%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF53.8%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$9.31BShare price x shares outstanding.
Enterprise value$12.28BMarket cap + total debt - cash - short-term investments.
P/E13.2xMarket cap / net income. Only when net income is positive.
P/S2.65xMarket cap / revenue.
P/FCF8.15xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF7.71xMarket cap / cash from operations, when positive.
EV/Sales3.50xEnterprise value / revenue.
EV/EBIT12.4xEnterprise value / operating income, when both are positive.
EV/EBITDA11.8xEnterprise value / EBITDA, when both are positive.
EV/FCF10.8xEnterprise value / free cash flow, when both are positive.
FCF yield12.3%Free cash flow / market cap.
Earnings yield7.6%Net income / market cap (the inverse of P/E).
Dividend yield2.0%Dividends paid over the period / market cap.
Shareholder yield8.6%(Dividends paid + share buybacks) / market cap.
PEG0.54xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was Match Group, Inc.'s revenue in fiscal 2025?

Match Group, Inc. reported revenue of $3.49B for fiscal 2025, 0.2% higher than the year before.

Was Match Group, Inc. profitable in fiscal 2025?

Yes. Net income was $613.4M, a net margin of 17.6%.

How much free cash flow did Match Group, Inc. generate in fiscal 2025?

Cash from operations of $1.08B minus capital expenditures of $56.8M left free cash flow of $1.02B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Match Group, Inc.